These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 28406092

  • 1. Safety of azathioprine and 6-mercaptopurine in patients with inflammatory bowel disease naïve to thiopurine treatment
.
    Alaish R, Lundgren D, Suhr OB, Werner M, Karling P.
    Int J Clin Pharmacol Ther; 2017 Jul; 55(7):594-600. PubMed ID: 28406092
    [Abstract] [Full Text] [Related]

  • 2. More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing.
    Broekman MMTJ, Coenen MJH, van Marrewijk CJ, Wanten GJA, Wong DR, Verbeek ALM, Klungel OH, Hooymans PM, Guchelaar HJ, Scheffer H, Derijks LJJ, de Jong DJ, TOPIC Recruitment Team.
    Inflamm Bowel Dis; 2017 Oct; 23(10):1873-1881. PubMed ID: 28644183
    [Abstract] [Full Text] [Related]

  • 3. Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine.
    Dubinsky MC, Feldman EJ, Abreu MT, Targan SR, Vasiliauskas EA.
    Am J Gastroenterol; 2003 May; 98(5):1058-63. PubMed ID: 12809828
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of tolerance to mercaptopurine in patients with inflammatory bowel disease and gastrointestinal intolerance to azathioprine.
    Bastida G, Alvarez-Sotomayor D, Aguas M, Iborra M, Del Hoyo J, Béjar-Serrano S, Garrido-Marín A, Valero-Pérez E, Nos P.
    Gastroenterol Hepatol; 2024 May; 47(5):473-480. PubMed ID: 38072359
    [Abstract] [Full Text] [Related]

  • 5. Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.
    Coenen MJ, de Jong DJ, van Marrewijk CJ, Derijks LJ, Vermeulen SH, Wong DR, Klungel OH, Verbeek AL, Hooymans PM, Peters WH, te Morsche RH, Newman WG, Scheffer H, Guchelaar HJ, Franke B, TOPIC Recruitment Team.
    Gastroenterology; 2015 Oct; 149(4):907-17.e7. PubMed ID: 26072396
    [Abstract] [Full Text] [Related]

  • 6. Evolution of thiopurine use in pediatric inflammatory bowel disease in an academic center.
    Banerjee S, Bishop WP.
    J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):324-30. PubMed ID: 16954954
    [Abstract] [Full Text] [Related]

  • 7. NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD.
    Kakuta Y, Naito T, Onodera M, Kuroha M, Kimura T, Shiga H, Endo K, Negoro K, Kinouchi Y, Shimosegawa T.
    Pharmacogenomics J; 2016 Jun; 16(3):280-5. PubMed ID: 26076924
    [Abstract] [Full Text] [Related]

  • 8. Increased dosing requirements for 6-mercaptopurine and azathioprine in inflammatory bowel disease patients six years and younger.
    Grossman AB, Noble AJ, Mamula P, Baldassano RN.
    Inflamm Bowel Dis; 2008 Jun; 14(6):750-5. PubMed ID: 18266236
    [Abstract] [Full Text] [Related]

  • 9. Clinical Value of Mercaptopurine After Failing Azathioprine Therapy in Patients With Inflammatory Bowel Disease.
    Meijer B, Seinen ML, Leijte NN, Mulder CJ, van Bodegraven AA, de Boer NK.
    Ther Drug Monit; 2016 Aug; 38(4):463-70. PubMed ID: 27158876
    [Abstract] [Full Text] [Related]

  • 10. Hepatotoxicity of 6-mercaptopurine (6-MP) and Azathioprine (AZA) in adult IBD patients.
    Shaye OA, Yadegari M, Abreu MT, Poordad F, Simon K, Martin P, Papadakis KA, Ippoliti A, Vasiliauskas E, Tran TT.
    Am J Gastroenterol; 2007 Nov; 102(11):2488-94. PubMed ID: 17764490
    [Abstract] [Full Text] [Related]

  • 11. The efficacy of low dose azathioprine/6-mercaptopurine in patients with inflammatory bowel disease.
    Kim DU, Kim YH, Kim BJ, Chang DK, Son HJ, Rhee PL, Kim JJ, Rhee JC.
    Hepatogastroenterology; 2009 Nov; 56(94-95):1395-402. PubMed ID: 19950798
    [Abstract] [Full Text] [Related]

  • 12. [The frequency and the course of the adverse effects of azathioprine/6-mercaptopurine treatment in patients with inflammatory bowel disease].
    Kim JH, Cheon JH, Kim WH.
    Korean J Gastroenterol; 2008 May; 51(5):291-7. PubMed ID: 18516013
    [Abstract] [Full Text] [Related]

  • 13. Thiopurines related malignancies in inflammatory bowel disease: local experience in Granada, Spain.
    Gómez-García M, Cabello-Tapia MJ, Sánchez-Capilla AD, De Teresa-Galván J, Redondo-Cerezo E.
    World J Gastroenterol; 2013 Aug 14; 19(30):4877-86. PubMed ID: 23946592
    [Abstract] [Full Text] [Related]

  • 14. Thiopurine-induced myelotoxicity in patients with inflammatory bowel disease: a review.
    Gisbert JP, Gomollón F.
    Am J Gastroenterol; 2008 Jul 14; 103(7):1783-800. PubMed ID: 18557712
    [Abstract] [Full Text] [Related]

  • 15. The drug-survival of low-dose thioguanine in patients with inflammatory bowel disease: a retrospective observational study.
    Gensmyr-Singer H, Werner M, Karling P.
    Therap Adv Gastroenterol; 2024 Jul 14; 17():17562848241228064. PubMed ID: 38384282
    [Abstract] [Full Text] [Related]

  • 16. Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease.
    Ansari A, Patel N, Sanderson J, O'Donohue J, Duley JA, Florin TH.
    Aliment Pharmacol Ther; 2010 Mar 14; 31(6):640-7. PubMed ID: 20015102
    [Abstract] [Full Text] [Related]

  • 17. 6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment.
    Derijks LJ, de Jong DJ, Gilissen LP, Engels LG, Hooymans PM, Jansen JB, Mulder CJ.
    Eur J Gastroenterol Hepatol; 2003 Jan 14; 15(1):63-7. PubMed ID: 12544696
    [Abstract] [Full Text] [Related]

  • 18. Split-dose administration of thiopurine drugs: a novel and effective strategy for managing preferential 6-MMP metabolism.
    Shih DQ, Nguyen M, Zheng L, Ibanez P, Mei L, Kwan LY, Bradford K, Ting C, Targan SR, Vasiliauskas EA.
    Aliment Pharmacol Ther; 2012 Sep 14; 36(5):449-58. PubMed ID: 22784257
    [Abstract] [Full Text] [Related]

  • 19. Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines.
    Dotan I, Werner L, Vigodman S, Agarwal S, Pfeffer J, Horowitz N, Malter L, Abreu M, Ullman T, Guzner-Gur H, Halpern Z, Mayer L.
    Inflamm Bowel Dis; 2012 Feb 14; 18(2):261-8. PubMed ID: 21438101
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine.
    Wahed M, Louis-Auguste JR, Baxter LM, Limdi JK, McCartney SA, Lindsay JO, Bloom SL.
    Aliment Pharmacol Ther; 2009 Sep 15; 30(6):614-20. PubMed ID: 19552632
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.